J H Cove

Author PubWeight™ 53.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990 4.03
2 Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother 1989 2.62
3 Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002 2.34
4 Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993 2.25
5 Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003 2.22
6 Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001 2.14
7 A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999 2.04
8 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 1998 1.94
9 Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997 1.63
10 Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol 1990 1.61
11 Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 1995 1.57
12 Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989 1.40
13 Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001 1.25
14 Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 1996 1.12
15 Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994 1.07
16 Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992 1.06
17 Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993 1.01
18 Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996 1.00
19 Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology 1998 0.97
20 Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne. Br J Dermatol 2007 0.95
21 Multiple mechanisms of erythromycin resistance. J Antimicrob Chemother 1990 0.94
22 ABC proteins and antibiotic drug resistance: is it all about transport? Biochem Soc Trans 2005 0.92
23 A note on a selective medium for the isolation of cutaneous propionibacteria. J Appl Bacteriol 1982 0.90
24 The effect of benzoyl peroxide on cutaneous micro-organisms in vitro. J Appl Bacteriol 1983 0.90
25 Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes. J Antimicrob Chemother 1989 0.89
26 Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003 0.88
27 Effects of oxygen concentration on biomass production, maximum specific growth rate and extracellular enzyme production by three species of cutaneous propionibacteria grown in continuous culture. J Gen Microbiol 1983 0.88
28 Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993 0.87
29 Cytolysin gene expression in Enterococcus faecalis is regulated in response to aerobiosis conditions. Mol Genet Genomics 2003 0.86
30 Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988 0.85
31 Plasmid effects on secondary metabolite production by a streptomycete synthesizing an anthelmintic macrolide. J Gen Microbiol 1991 0.84
32 Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol 2005 0.82
33 Topical antibiotic therapy: current status and future prospects. Drugs Exp Clin Res 1990 0.82
34 The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996 0.81
35 Evaluation of a biochemical test scheme for identifying clinical isolates of Enterococcus faecalis and Enterococcus faecium. Lett Appl Microbiol 2001 0.80
36 Physiological factors affecting streptomycin production by Streptomyces griseus ATCC 12475 in batch and continuous culture. FEMS Microbiol Lett 1995 0.79
37 The vitamin requirements of staphylococci isolated from human skin. J Appl Bacteriol 1980 0.79
38 Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro. Dermatology 1998 0.78
39 Acne vulgaris: is the bacterial population size significant? Br J Dermatol 1980 0.77
40 Depression of streptomycin production by Streptomyces griseus at elevated growth temperature: studies using gene fusions. Microbiology 1995 0.77
41 Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris. Br J Dermatol 2009 0.77
42 Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. J Antimicrob Chemother 2000 0.76
43 An analysis of sebum excretion rate, bacterial population and the production rate of free fatty acids on human skin. Br J Dermatol 1980 0.76
44 In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms. Infect Immun 1995 0.75
45 Inflammatory levels of interleukin 1 alpha are present in the majority of open comedones in acne vulgaris. Arch Dermatol 1991 0.75
46 The vitamin requirements of Staphylococcus cohnii. J Appl Bacteriol 1983 0.75
47 Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride. Clin Exp Dermatol 1997 0.75
48 Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment. Am J Clin Dermatol 2001 0.75
49 Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris. Br J Dermatol 1994 0.75
50 Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines. J Invest Dermatol 1993 0.75
51 The use of PCR to isolate a putative ABC transporter from Saccharopolyspora erythraea. FEMS Microbiol Lett 1995 0.75